Meredith Y Smith

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Topics

Rheumatoid Arthritis

Decision Making

Interstitial Lung Disease

Optical Coherence Tomography

Top Venues

Health research policy and systems

Journal of public health policy

JMIR research protocols

This page only lists publications with an associated author ORCID identifier.

Publications

Meredith Y Smith, Elaine H Morrato, Nallely Mora, Viviana Nguyen, Hilary Pinnock, Almut G Winterstein
The Reporting Recommendations Intended for Pharmaceutical Risk Minimization Evaluation Studies: Standards for Reporting of Implementation Studies Extension (RIMES-SE). Drug safety 47 (7) (2024)
Meredith Y Smith, Elaine H Morrato, Nallely Mora, Viviana Nguyen, Hilary Pinnock, Almut G Winterstein
The Reporting Recommendations Intended for Pharmaceutical Risk Minimization Evaluation Studies: Standards for Reporting of Implementation Studies Extension (RIMES-SE). Drug safety 47 (7) (2024)
Meredith Y Smith, Elaine H Morrato, Nallely Mora, Viviana Nguyen, Hilary Pinnock, Almut G Winterstein
The Reporting Recommendations Intended for Pharmaceutical Risk Minimization Evaluation Studies: Standards for Reporting of Implementation Studies Extension (RIMES-SE). Drug safety 47 (7) (2024)
Meredith Y Smith, Bridget Gaglio, Milena Anatchkova
The use of implementation science theories, models, and frameworks in implementation research for medicinal products: A scoping review. Health research policy and systems 22 (1) (2024)
Meredith Y Smith, Bridget Gaglio, Milena Anatchkova
The use of implementation science theories, models, and frameworks in implementation research for medicinal products: A scoping review. Health research policy and systems 22 (1) (2024)
Meredith Y Smith, Elaine H Morrato, Nallely Mora, Viviana Nguyen, Hilary Pinnock, Almut G Winterstein
The Reporting Recommendations Intended for Pharmaceutical Risk Minimization Evaluation Studies: Standards for Reporting of Implementation Studies Extension (RIMES-SE). Drug safety (2024)
Meredith Y Smith, Bridget Gaglio, Milena Anatchkova
The use of implementation science theories, models, and frameworks in implementation research for medicinal products: A scoping review. Health research policy and systems 22 (1) (2024)
Almut G Winterstein, Vera Ehrenstein, Jeffrey S Brown, Til Stürmer, Meredith Y Smith
A Road Map for Peer Review of Real-World Evidence Studies on Safety and Effectiveness of Treatments. Diabetes care 46 (8) (2023)
Meredith Y Smith, Sandy-Asari Hogan, Susan M Jack, Robin Taylor Wilson, Mark Oremus
The case for using mixed methods for designing, implementing, and disseminating evidence-based interventions for public health practice. Journal of public health policy 43 (2) (2022)
Lisa Nugent, Robin C Anthony Kouyaté, Shawna Jackson, Meredith Y Smith
Development of a Digital Health Intervention for Rheumatoid Arthritis Symptom Management in a Biotechnology Industry Context: Protocol for the Application of a Human-Centered Design Framework. JMIR research protocols 11 (3) (2022)
Meredith Y Smith, Sarah Frise, Jane Feron, Ryan Marshall
Improving the Safety of Medicines via Digital Technology: An Assessment of the Scope and Quality of Risk Minimization Websites in the United States and United Kingdom. Drug safety 45 (3) (2022)
Meredith Y Smith, Priya Bahri, James A Gaudino, Rafael S Moreira, Gregory M Danyluk, Sheila L Palevsky
The role of epidemiologists in communicating SARS-CoV-2 evidence: a call for adopting standards. International journal of epidemiology 50 (5) (2021)
Rania Mouchantaf, Doris Auth, Yola Moride, June Raine, Soon Young Han, Meredith Y Smith
Risk Management for the 21st Century: Current Status and Future Needs. Drug safety 44 (4) (2021)
Meredith Y Smith, Janine Astrid van Til, Rachael L DiSantostefano, A Brett Hauber, Kevin Marsh
Quantitative Benefit-Risk Assessment: State of the Practice Within Industry. Therapeutic innovation & regulatory science 55 (2) (2020)